143 related articles for article (PubMed ID: 30615214)
1. Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients.
Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Sousa A; Lemos C
Ann Neurol; 2019 Feb; 85(2):251-258. PubMed ID: 30615214
[TBL] [Abstract][Full Text] [Related]
2. mtDNA copy number associated with age of onset in familial amyloid polyneuropathy.
Santos D; Santos MJ; Alves-Ferreira M; Coelho T; Sequeiros J; Alonso I; Oliveira P; Sousa A; Lemos C; Grazina M
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):300-304. PubMed ID: 29018163
[TBL] [Abstract][Full Text] [Related]
3. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
[TBL] [Abstract][Full Text] [Related]
4. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
[TBL] [Abstract][Full Text] [Related]
5. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
6. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
Rudolph T; Kurz MW; Farbu E
Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
[TBL] [Abstract][Full Text] [Related]
7.
Dias A; Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Alonso I; Sousa A; Lemos C
Ann Clin Transl Neurol; 2019 Apr; 6(4):748-754. PubMed ID: 31019999
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
[TBL] [Abstract][Full Text] [Related]
10. Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.
Alves-Ferreira M; Azevedo A; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
Amyloid; 2021 Jun; 28(2):100-106. PubMed ID: 33461327
[TBL] [Abstract][Full Text] [Related]
11. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani LL; Lozeron P; Théaudin M; Mincheva Z; Signate A; Ducot B; Algalarrondo V; Denier C; Adam C; Nicolas G; Samuel D; Slama MS; Lacroix C; Misrahi M; Adams D;
Ann Neurol; 2015 Dec; 78(6):901-16. PubMed ID: 26369527
[TBL] [Abstract][Full Text] [Related]
13. On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
Zaros C; Genin E; Hellman U; Saporta MA; Languille L; Wadington-Cruz M; Suhr O; Misrahi M; Planté-Bordeneuve V
Ann Hum Genet; 2008 Jul; 72(Pt 4):478-84. PubMed ID: 18460047
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
15. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
Andrés N; Poza JJ; Martí Massó JF
Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of familial amyloid polyneuropathy type I in Argentina].
Pérez G; Romero MC; Trigo P; Lendoire J; Imventarza O; Nesse A
Medicina (B Aires); 2008; 68(4):273-81. PubMed ID: 18786882
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Oide T; Arima K; Yamazaki M; Hanyu N; Ikeda S
Amyloid; 2004 Sep; 11(3):191-9. PubMed ID: 15523922
[TBL] [Abstract][Full Text] [Related]
18. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
[TBL] [Abstract][Full Text] [Related]
19. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
20. [Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina].
Chaves M; Bettini M; Marciano S; Sáez S; Cristiano E; Rugiero M
Medicina (B Aires); 2016; 76(2):105-8. PubMed ID: 27135849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
